508 related articles for article (PubMed ID: 29082668)
1. Breathomics from exhaled volatile organic compounds in pediatric asthma.
Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
[TBL] [Abstract][Full Text] [Related]
2. Exhaled volatile organic compounds in adult asthma: a systematic review.
Azim A; Barber C; Dennison P; Riley J; Howarth P
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273044
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
[TBL] [Abstract][Full Text] [Related]
4. Can exhaled volatile organic compounds predict asthma exacerbations in children?
van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
[TBL] [Abstract][Full Text] [Related]
5. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
[TBL] [Abstract][Full Text] [Related]
6. The versatile use of exhaled volatile organic compounds in human health and disease.
Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
[TBL] [Abstract][Full Text] [Related]
7. Breathomics in the setting of asthma and chronic obstructive pulmonary disease.
Bos LD; Sterk PJ; Fowler SJ
J Allergy Clin Immunol; 2016 Oct; 138(4):970-976. PubMed ID: 27590400
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions.
Fens N; van der Schee MP; Brinkman P; Sterk PJ
Clin Exp Allergy; 2013 Jul; 43(7):705-15. PubMed ID: 23786277
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate volatilome allows sensitive diagnosis of persistent asthma.
Cavaleiro Rufo J; Paciência I; Mendes FC; Farraia M; Rodolfo A; Silva D; de Oliveira Fernandes E; Delgado L; Moreira A
Allergy; 2019 Mar; 74(3):527-534. PubMed ID: 30156012
[TBL] [Abstract][Full Text] [Related]
10. Breathomics and treatable traits for chronic airway diseases.
Brinkman P; Zee AM; Wagener AH
Curr Opin Pulm Med; 2019 Jan; 25(1):94-100. PubMed ID: 30325789
[TBL] [Abstract][Full Text] [Related]
11. Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
Peel AM; Wilkinson M; Sinha A; Loke YK; Fowler SJ; Wilson AM
Respir Med; 2020 Aug; 169():105984. PubMed ID: 32510334
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath.
Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP
Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239
[TBL] [Abstract][Full Text] [Related]
13. Exhaled breath analysis by electronic nose in respiratory diseases.
Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
[TBL] [Abstract][Full Text] [Related]
14. A Clinical Breathomics Dataset.
Kuo PH; Jhong YC; Kuo TC; Hsu YT; Kuo CH; Tseng YJ
Sci Data; 2024 Feb; 11(1):203. PubMed ID: 38355591
[TBL] [Abstract][Full Text] [Related]
15. Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.
Ibrahim W; Carr L; Cordell R; Wilde MJ; Salman D; Monks PS; Thomas P; Brightling CE; Siddiqui S; Greening NJ
Thorax; 2021 May; 76(5):514-521. PubMed ID: 33414240
[TBL] [Abstract][Full Text] [Related]
16. Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine.
Sukul P; Schubert JK; Zanaty K; Trefz P; Sinha A; Kamysek S; Miekisch W
Sci Rep; 2020 Aug; 10(1):14109. PubMed ID: 32839494
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
[TBL] [Abstract][Full Text] [Related]
18. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
van Mastrigt E; de Jongste JC; Pijnenburg MW
Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
[TBL] [Abstract][Full Text] [Related]
20. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
